Bavarian seeks approval of freeze-dried smallpox vaccine in the US
Bavarian Nordic has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for a freeze-dried formulation of Jynneos, the only approved vaccine against mpox, formerly known as monkeypox.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Bavarian Nordic starts commercial launch of pox vaccine
For subscribers
Bavarian Nordic's pox vaccine approved in Switzerland
For subscribers